References
- Hellal F, Hurtado A, Ruschel J, et al. Microtubule stabilization reduces scarring and causes axon regeneration after spinal cord injury. Science (New York) 2011;331:928–31.
- Garcia-Alias G, Lopez-Vales R, Fores J, et al. Acute transplantation of olfactory ensheathing cells or Schwann cells promotes recovery after spinal cord injury in the rat. J Neurosci Res 2004;75:632–41.
- Guizar-Sahagun G, Ibarra A, Espitia A, et al. Glutathione monoethyl ester improves functional recovery, enhances neuron survival, and stabilizes spinal cord blood flow after spinal cord injury in rats. Neuroscience 2005;130:639–49.
- Tysseling-Mattiace VM, Sahni V, Niece KL, et al. Self-assembling nanofibers inhibit glial scar formation and promote axon elongation after spinal cord injury. J Neurosci 2008;28:3814–23.
- Hwang JH, Lee JH, Lee KH, et al. Cyclosporine A attenuates hypoxic-ischemic brain injury in newborn rats. Brain Res 2010;1359:208–15.
- Hui KK, Liadis N, Robertson J, et al. Calcineurin inhibition enhances motor neuron survival following injury. J Cell Mol Med 2010;14:671–86.
- Kniesel U, Wolburg H. Tight junctions of the blood-brain barrier. Cell Mol Neurobiol 2000;20:57–76.
- Tan EY, Law JW, Wang CH, Lee AY. Development of a cell transducible RhoA inhibitor TAT-C3 transferase and its encapsulation in biocompatible microspheres to promote survival and enhance regeneration of severed neurons. Pharmaceut Res 2007;24:2297–308.
- Begley DJ. Understanding and circumventing the blood-brain barrier. Acta Paediatr Suppl 2003;92:83–91.
- Agarwal A, Lariya N, Saraogi G, et al. Nanoparticles as novel carrier for brain delivery: a review. Curr Pharmaceut Des 2009;15:917–25.
- Jain RA. The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices. Biomaterials 2000;21:2475–90.
- Liu Y, Wang CY, Kong XH, et al. Novel multifunctional polyethylene glycol-transactivating-transduction protein-modified liposomes cross the blood-spinal cord barrier after spinal cord injury. J Drug Target 2010;18:420–9.
- Wang H, Zhao P, Liang X, et al. Folate-PEG coated cationic modified chitosan–cholesterol liposomes for tumor-targeted drug delivery. Biomaterials 2010;31:4129–38.
- Basso DM, Beattie MS, Bresnahan JC. A sensitive and reliable locomotor rating scale for open field testing in rats. J Neurotrauma 1995;12:1–21.
- Rabchevsky AG, Fugaccia I, Sullivan PG, Scheff SW. Cyclosporin A treatment following spinal cord injury to the rat: behavioral effects and stereological assessment of tissue sparing. J Neurotrauma 2001;18:513–22.
- Lindholm A. Factors influencing the pharmacokinetics of cyclosporine in man. Ther Drug Monit 1991;13:465–77.
- Liu L, Guo K, Lu J, et al. Biologically active core/shell nanoparticles self-assembled from cholesterol-terminated PEG-TAT for drug delivery across the blood-brain barrier. Biomaterials 2008;29:1509–17.
- Kawakami M, Yoshimoto T, Nakagata N, et al. Effects of cyclosporin A administration on gene expression in rat brain. Brain Inj 2011;25:614–23.
- Sullivan PG, Rabchevsky AG, Hicks RR, et al. Dose-response curve and optimal dosing regimen of cyclosporin A after traumatic brain injury in rats. Neuroscience 2000;101:289–95.
- Sullivan PG, Rabchevsky AG, Waldmeier PC, Springer JE. Mitochondrial permeability transition in CNS trauma: cause or effect of neuronal cell death? J Neurosci Res 2005;79:231–9.
- Maikos JT, Shreiber DI. Immediate damage to the blood-spinal cord barrier due to mechanical trauma. J Neurotrauma 2007;24:492–507.
- Pittet MJ, Swirski FK, Reynolds F, et al. Labeling of immune cells for in vivo imaging using magnetofluorescent nanoparticles. Nat Protoc 2006;1:73–9.
- Kaplan IM, Wadia JS, Dowdy SF. Cationic TAT peptide transduction domain enters cells by macropinocytosis. J Control Release 2005;102:247–53.